These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model. Gaspar RC; Villarreal SA; Bowles N; Hepler RW; Joyce JG; Shughrue PJ Exp Neurol; 2010 Jun; 223(2):394-400. PubMed ID: 19744481 [TBL] [Abstract][Full Text] [Related]
4. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice. Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032 [TBL] [Abstract][Full Text] [Related]
5. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
6. Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease. Mohajeri MH; Kuehnle K; Li H; Poirier R; Tracy J; Nitsch RM FEBS Lett; 2004 Mar; 562(1-3):16-21. PubMed ID: 15043995 [TBL] [Abstract][Full Text] [Related]
7. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology. Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347 [TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Simard AR; Soulet D; Gowing G; Julien JP; Rivest S Neuron; 2006 Feb; 49(4):489-502. PubMed ID: 16476660 [TBL] [Abstract][Full Text] [Related]
10. Three-dimensional and fractal analyses of assemblies of amyloid beta protein subtypes [Abeta40 and Abeta42(43)] in canine senile plaques. Miyawaki K; Nakayama H; Matsuno S; Tamaoka A; Doi K Acta Neuropathol; 2002 Mar; 103(3):228-36. PubMed ID: 11907802 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease. Lee JY; Kweon HS; Cho E; Lee JY; Byun HR; Kim DH; Kim YH; Han PL; Koh JY Neurosci Lett; 2007 Aug; 423(1):82-7. PubMed ID: 17662525 [TBL] [Abstract][Full Text] [Related]
12. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
13. Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques. Kumar-Singh S Genes Brain Behav; 2008 Feb; 7 Suppl 1():67-82. PubMed ID: 18184371 [TBL] [Abstract][Full Text] [Related]
14. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease? Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173 [TBL] [Abstract][Full Text] [Related]
15. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Chen G; Chen KS; Knox J; Inglis J; Bernard A; Martin SJ; Justice A; McConlogue L; Games D; Freedman SB; Morris RG Nature; 2000 Dec 21-28; 408(6815):975-9. PubMed ID: 11140684 [TBL] [Abstract][Full Text] [Related]
16. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Janus C; Pearson J; McLaurin J; Mathews PM; Jiang Y; Schmidt SD; Chishti MA; Horne P; Heslin D; French J; Mount HT; Nixon RA; Mercken M; Bergeron C; Fraser PE; St George-Hyslop P; Westaway D Nature; 2000 Dec 21-28; 408(6815):979-82. PubMed ID: 11140685 [TBL] [Abstract][Full Text] [Related]
17. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001 [TBL] [Abstract][Full Text] [Related]
18. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice. Lee JY; Friedman JE; Angel I; Kozak A; Koh JY Neurobiol Aging; 2004; 25(10):1315-21. PubMed ID: 15465629 [TBL] [Abstract][Full Text] [Related]
19. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Bard F; Cannon C; Barbour R; Burke RL; Games D; Grajeda H; Guido T; Hu K; Huang J; Johnson-Wood K; Khan K; Kholodenko D; Lee M; Lieberburg I; Motter R; Nguyen M; Soriano F; Vasquez N; Weiss K; Welch B; Seubert P; Schenk D; Yednock T Nat Med; 2000 Aug; 6(8):916-9. PubMed ID: 10932230 [TBL] [Abstract][Full Text] [Related]
20. Biomedicine. Tauists and beta-aptists united--well almost! Lee VM Science; 2001 Aug; 293(5534):1446-7. PubMed ID: 11520974 [No Abstract] [Full Text] [Related] [Next] [New Search]